Market Overview:
The global rigid packaging for the pharmaceutical market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing demand for generic drugs, rising awareness about hygiene and safety, and growing investments by key players in research and development (R&D) activities. Based on type, the global rigid packaging for the pharmaceutical market can be segmented into plastic, metal, paper, glass, and others. Of these segments, plastic is expected to account for the largest share of this market during the forecast period. This can be attributed to its properties such as durability and resistance to moisture and chemicals. Based on application, medical tools & equipment is expected to account for the largest share of this market duringthe forecast period. This can be attributedto th egrowing demandfor medical devicesand equipment worldwide due To th eincreasing prevalenceof lifestyle-related diseasesand an aging population .
Product Definition:
Rigid packaging is a type of packaging that holds its shape and does not deform when pressure or weight is applied. It is often used for pharmaceuticals, as it can help to protect the product from damage during transport. Rigid packaging can also be customized to fit the specific needs of a product, which can be helpful in promoting brand recognition.
Plastic:
Plastic is a generic material which can be categorized into Polyethylene Terephthalate (PET), Polypropylene (PP), High-Density Polyethylene (HDPE) and Low-Density Polyethylene (LDPE). The most commonly used plastic in the rigid packaging market for pharmaceuticals is HDPE owing to its properties such as high impact resistance, good barrier protection and excellent clarity.
Metal:
Metal and its usage in rigid packaging for the pharmaceutical market is a very important aspect. The metal used can be varied as per the requirement of the product. Some of them are aluminum, stainless steel, copper & brass & alloys such as bronzes & tin; titanium dioxide which is also known as titanium.
Application Insights:
The medical tools & equipment application segment accounted for the largest revenue share in 2017 and is projected to continue its dominance over the forecast period. This can be attributed to increasing investments in R&D for developing new products using rigid packaging as it offers various advantages, such as protection from external influences, high impact resistance, and ease of handling.
Rigid packaging solutions are also used for generic drugs application owing to their ability to preserve drug quality throughout the supply chain. These solutions help manufacturers deliver consistent performance across multiple distribution channels without compromising on product quality or safety. Generic drugs are usually produced in large quantities which require low cost distribution solution since they are sold at lower prices than branded counterparts do.
Regional Analysis:
North America accounted for the largest revenue share in 2017 owing to the presence of a large number of pharmaceutical companies and well-established healthcare infrastructure. The region is expected to maintain its dominance during the forecast period due to factors such as increasing geriatric population, rising chronic diseases, and growing awareness about Rigid Packaging (Rigid Plastics).
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rapid economic growth in emerging countries such as China and India. In addition, government initiatives encouraging generic manufacturing are also expected favorably impact regional growth. For instance, China’s 12th Five Year Plan from 2016 includes an initiative called “Make in India†which encourages foreign investment by reducing trade barriers for manufactured goods including medicines. This will create ample opportunities for global players operating in Asia Pacific market space over next few years.
Growth Factors:
- Pharmaceutical companies are increasingly looking for ways to improve their packaging and protect their products from damage during transport. Rigid packaging offers a number of advantages over other types of packaging, including greater protection and durability.
- Rigid packaging is also easier to stack and store, which can help reduce shipping costs and save space in warehouses.
- Pharmaceutical manufacturers are also looking for ways to improve the appearance of their products in order to stand out on store shelves. Rigid packaging can help create a more professional appearance that consumers will trust.
- In addition, rigid packaging can be customized to include specific branding or marketing messages that will appeal to customers. This can help pharmaceutical companies differentiate their products from those of their competitors.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rigid Packaging for the Pharmaceutical Market Research Report
By Type
Plastic, Metal, Paper, Glass, Others
By Application
Medical Tools & Equipment, Generic Drugs, Branded Drugs
By Companies
Amcor, Bemis Company, Berry Global, Garresheimer, WestRock, Corning Shong Pharmaceutical Glass
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Rigid Packaging for the Pharmaceutical Market Report Segments:
The global Rigid Packaging for the Pharmaceutical market is segmented on the basis of:
Types
Plastic, Metal, Paper, Glass, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Tools & Equipment, Generic Drugs, Branded Drugs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amcor
- Bemis Company
- Berry Global
- Garresheimer
- WestRock
- Corning Shong Pharmaceutical Glass
Highlights of The Rigid Packaging for the Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plastic
- Metal
- Paper
- Glass
- Others
- By Application:
- Medical Tools & Equipment
- Generic Drugs
- Branded Drugs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rigid Packaging for the Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rigid packaging is a type of packaging that is used for pharmaceuticals. It is made from strong materials, such as plastic or metal, and it has a tight seal to prevent the drugs from leaking. This type of packaging is often used for medications that are sensitive to heat or moisture.
Some of the major players in the rigid packaging for the pharmaceutical market are Amcor, Bemis Company, Berry Global, Garresheimer, WestRock, Corning Shong Pharmaceutical Glass.
The rigid packaging for the pharmaceutical market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rigid Packaging for the Pharmaceutical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rigid Packaging for the Pharmaceutical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rigid Packaging for the Pharmaceutical Market - Supply Chain
4.5. Global Rigid Packaging for the Pharmaceutical Market Forecast
4.5.1. Rigid Packaging for the Pharmaceutical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rigid Packaging for the Pharmaceutical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rigid Packaging for the Pharmaceutical Market Absolute $ Opportunity
5. Global Rigid Packaging for the Pharmaceutical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
5.3.1. Plastic
5.3.2. Metal
5.3.3. Paper
5.3.4. Glass
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rigid Packaging for the Pharmaceutical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
6.3.1. Medical Tools & Equipment
6.3.2. Generic Drugs
6.3.3. Branded Drugs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rigid Packaging for the Pharmaceutical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rigid Packaging for the Pharmaceutical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rigid Packaging for the Pharmaceutical Demand Share Forecast, 2019-2026
9. North America Rigid Packaging for the Pharmaceutical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
9.4.1. Medical Tools & Equipment
9.4.2. Generic Drugs
9.4.3. Branded Drugs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
9.7.1. Plastic
9.7.2. Metal
9.7.3. Paper
9.7.4. Glass
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rigid Packaging for the Pharmaceutical Demand Share Forecast, 2019-2026
10. Latin America Rigid Packaging for the Pharmaceutical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
10.4.1. Medical Tools & Equipment
10.4.2. Generic Drugs
10.4.3. Branded Drugs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
10.7.1. Plastic
10.7.2. Metal
10.7.3. Paper
10.7.4. Glass
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rigid Packaging for the Pharmaceutical Demand Share Forecast, 2019-2026
11. Europe Rigid Packaging for the Pharmaceutical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
11.4.1. Medical Tools & Equipment
11.4.2. Generic Drugs
11.4.3. Branded Drugs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
11.7.1. Plastic
11.7.2. Metal
11.7.3. Paper
11.7.4. Glass
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rigid Packaging for the Pharmaceutical Demand Share, 2019-2026
12. Asia Pacific Rigid Packaging for the Pharmaceutical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
12.4.1. Medical Tools & Equipment
12.4.2. Generic Drugs
12.4.3. Branded Drugs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
12.7.1. Plastic
12.7.2. Metal
12.7.3. Paper
12.7.4. Glass
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rigid Packaging for the Pharmaceutical Demand Share, 2019-2026
13. Middle East & Africa Rigid Packaging for the Pharmaceutical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Application
13.4.1. Medical Tools & Equipment
13.4.2. Generic Drugs
13.4.3. Branded Drugs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rigid Packaging for the Pharmaceutical Market Size and Volume Forecast by Type
13.7.1. Plastic
13.7.2. Metal
13.7.3. Paper
13.7.4. Glass
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rigid Packaging for the Pharmaceutical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rigid Packaging for the Pharmaceutical Market: Market Share Analysis
14.2. Rigid Packaging for the Pharmaceutical Distributors and Customers
14.3. Rigid Packaging for the Pharmaceutical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amcor
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bemis Company
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Berry Global
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Garresheimer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. WestRock
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Corning Shong Pharmaceutical Glass
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
